Ponezumab - CAS 1178862-65-1

Ponezumab (PF-04360365), a humanized anti-amyloid IgG2 monoclonal antibody, effectively lowers Aβ levels in the central nervous system and enhances learning and memory performance in mouse models. It holds potential for Alzheimer's disease research [1].

EGFR

Angiogenesis, JAK/STAT signaling, Tyrosine Kinase/Adaptors

1178796

-20°C

Ice Packs

Inhibitory Antibodies